 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Tactile Systems Technology, Inc. (TCMD) a medical technology company, develops and provides medical devices for the treatment of underserved chronic diseases in the United States. 
It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema; Entre System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, treatment, and share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest for the treatment of retained pulmonary secretions, such as bronchiectasis, cystic fibrosis, and various neuromuscular disorders.
Shares have formed a bullish "cup and handle" following the company's latest quarterly report. On May 8th, Tactile Systems Technology (TCMD) reported a 1st Quarter March 2023 loss of $0.03 per share on revenue of $58.8 million. The consensus estimate was a loss of $0.27 per share on revenue of $53.9 million. Revenue grew 22.7% on a year-over-year basis.
Guided Higher: The company said it expects 2023 revenue of $271.0 million to $275.0 million. The company's previous guidance was revenue of $269.0 million to $273.0 million and the current consensus revenue estimate is $271.75 million for the year ending December 31, 2023.
Entry Point: $24.50
Trading Range: $6.29 - $24.76
Stop Loss: $23.00
Target Price: $27.00
